公司新闻

08
2022.11
新佐剂新冠肺炎疫苗ReCOV更新多项海外临床研究进展
27
2022.10
新佐剂重组四价HPV疫苗中国临床试验申请获得受理
19
2022.08
ReCOV与mRNA疫苗的比对研究已完成全部受试者入组及研究疫苗接种
10
2022.08
重组九价HPV疫苗III期临床试验进展

行业资讯

08
2022.12
文献解读:UDCA是高效疫苗的替代品?先别急着下结论!
27
2022.05
刘勇博士出席“中国疫苗创新发展-从研发到产业化”在线会议直播专题会议,共话疫苗产业发展
25
2022.01
从抗原到佐剂:疫苗百年里的中国声音
24
2022.01
新佐剂疫苗航母冲刺香港IPO 发力九价HPV、新冠疫苗和带状疱疹疫苗市场

学术论文

2023.03.06
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2
2022.05.11
The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV
2022.02.12
Lyophilized mRNA-lipid nanoparticles vaccine with long-term stability and high antigenicity against SARS-CoV-2
2021.11.09
A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques